Jennifer Evans Stacey - Net Worth and Insider Trading
Jennifer Evans Stacey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Evans Stacey owns 3 companies in total, including Antares Pharma Inc (ATRS) , Galera Therapeutics Inc (GRTX) , and Context Therapeutics Inc (CNTX) .
Click here to see the complete history of Jennifer Evans Stacey’s form 4 insider trades.
Insider Ownership Summary of Jennifer Evans Stacey
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRS | Antares Pharma Inc | 2014-05-29 | SVP & General Counsel & Secty |
GRTX | Galera Therapeutics Inc | 2021-10-08 | See Remarks |
CNTX | Context Therapeutics Inc | 2021-10-19 | director |
Jennifer Evans Stacey Trading Performance
Jennifer Evans Stacey Ownership Network
Ownership Network List of Jennifer Evans Stacey
Ownership Network Relation of Jennifer Evans Stacey
Jennifer Evans Stacey Owned Company Details
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Jennifer Evans Stacey is the SVP & General Counsel & Secty of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter J Graham , See Remarks Peter C Richardson , and Executive Vice President & CFO Fred M Powell .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
Jennifer Evans Stacey Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Evans Stacey. You might contact Jennifer Evans Stacey via mailing address: Auxilium Pharmaceuticals, Inc., 160 West Germantown Pike, Norristown Pa 19401.